Here are a few of the most interesting BioMarin statistics and facts I was able to dig up including revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
BioMarin Facts
- Website: Official Website
- Year Founded: 1997
- Headquarters: San Rafael, CA
- Founder(s): Christopher Starr and Glen Denison, Jr
- Current Chief Executive: Jean-Jacques Bienaime
What is BioMarin?
BioMarin is a global pharmaceutical company focused on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases. We remain steadfast to our original mission—to bring new treatments to market that will make a big impact on small patient populations. These patient populations are mostly children, suffering from diseases so rare, that the entire patient population can number as few as 1,000 people worldwide. These conditions are often inherited, difficult to diagnose, progressively debilitating, have few, if any, treatment options and are usually ignored. (source)
BioMarin Revenue Totals
BioMarin annual revenue:
- 2019: $1.704 billion
- 2018: $1.491 billion
- 2017: $1.313 billion
- 2016: $1.116 billion
- 2015: $889.9 million
BioMarin annual net income:
- 2019: $23.8 million net loss
- 2018: $77.2 million net loss
- 2017: $117 million net loss
- 2016: $630.2 million net loss
- 2015: $171.8 million net loss